European Medicines Agency Begins Safety Review for Calcifediol
The European Medicines Agency has commenced a periodic safety update assessment for the drug calcifediol. This action is part of the EMA's continuous efforts in pharmacovigilance to monitor and ensure the safety and effectiveness of medications available in the European Union.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.